Lataa...
Dramatic Response with Single-Agent Ibrutinib in Multiply Relapsed Marginal Zone Lymphoma with MYD88(L265P) Mutation
The B-cell receptor signaling pathway is important in the lymphomagenesis of many lymphomas, including marginal zone lymphoma (MZL). Herein we describe a case of extranodal MZL refractory to multiple lines of therapy. The presence of an IgM paraprotein prompted further evaluation, and the patient wa...
Tallennettuna:
| Julkaisussa: | Case Rep Oncol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
S. Karger AG
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649220/ https://ncbi.nlm.nih.gov/pubmed/29070995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000480292 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|